In 2020, Medicare spent the most on Eliquis, with more than 2.6 million Medicare Part D enrollees taking the blood thinner at a cost of nearly $10 billion, according to data released March 8 by AARP.
Read the full post on Becker's Hospital Review - Healthcare News
